Aimee Crombie
Senior VP and Head of Strategic Planning & OperationsMs. Aimee Crombie, Ph.D. is Senior Vice President & Head of Strategic Planning and Operations of Prelude Therapeutics Incorporated from 2022. Prior to joining Prelude, she was Vice President of Research at Trevena, Inc. where she oversaw drug discovery activities supporting target and hit identification, chemical lead optimization, and drug candidate selection. Aimee has contributed to the discovery of several small molecule including oliceridine. Prior to joining Trevena, Aimee was a Member of the Discovery Medicinal Chemistry group at Pfizer (formerly Wyeth) where she contributed to research programs in a variety of therapeutic areas including oncology, inflammation, neuroscience, cardiovascular, and musculoskeletal diseases. Aimee received her B.S. in Chemistry from the University of Pittsburgh and her Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology.
Positions
- Company NamePrelude Therapeutics IncorporatedStock CodePRLDPositionSenior VP and Head of Strategic Planning & OperationsColleagues
- KVKrishna VaddiFounder, CEO & Director
- PAPaul A. FriedmanIndependent Chairman of the Board
- BDBryant David LimCFO, Chief Legal Officer & Corporate Secretary
- PAPeggy A. ScherleChief Scientific Officer
- MPMadhu PudipeddiSenior Vice President of Technical Operations
- DBDavid BonitaIndependent Director
- VSVictor SandorIndependent Director
- KDKatina DortonIndependent Directors
